{"id":"W2023037752","doi":"10.1016/s1094-5539(02)00175-x","title":"Pharmacology of a new cyclic nucleotide phosphodiesterase type 4 inhibitor, V11294","year":2003,"lang":"en","type":"review","venue":"Pulmonary Pharmacology & Therapeutics","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Rolipram; Phosphodiesterase 3; Chemistry; Pharmacology; In vitro; In vivo; Phosphodiesterase; Cyclic nucleotide phosphodiesterase; Lipopolysaccharide; Cyclic nucleotide; Endocrinology; Internal medicine; Medicine; Biochemistry; Biology; Nucleotide; Enzyme","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004772504,0.001072832,0.001635482,0.0009998917,0.0002742595,0.0007351471,0.00100552,0.0009198749,0.002214022],"category_scores_gemma":[0.0003643931,0.0002360066,0.0004178363,0.0008879725,0.0003857174,0.0006890072,0.0003148868,0.001918386,0.002195062],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006291221,"about_ca_system_score_gemma":0.0007523256,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001370715,"about_ca_topic_score_gemma":0.003418278,"domain_scores_codex":[0.9998885,0.00001601446,0.00001254681,0.00002137959,0.0000444033,0.00001712047],"domain_scores_gemma":[0.9998941,0.00003686267,0.00002068475,0.000005295758,0.00002586975,0.00001714098],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004573803,0.0002668502,0.000153873,0.002961783,0.00009313822,0.0004664387,0.00003589586,0.0006303379,0.012779,0.00170392,0.02419164,0.9562597],"study_design_scores_gemma":[0.0005681304,0.001453381,0.002207902,0.0008484026,0.000280888,0.003859002,0.00004660011,0.0004719839,0.01099923,0.001502822,0.97771,0.00005178622],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003031506,0.9866489,0.001725284,0.0007402914,0.0005815543,0.00004457313,0.0001131444,0.00009253957,0.007022176],"genre_scores_gemma":[0.01029022,0.9767988,0.001961275,0.00108124,0.0003285718,0.00006461393,0.0002980552,0.00001428451,0.009162977],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002214022,"threshold_uncertainty_score":0.007406592,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05413083984290545,"score_gpt":0.3563719458341764,"score_spread":0.302241105991271,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}